Effects of ADHD and its medication on depression and anxiety in children and adolescents: a systematic review and meta-analysis

Author:

Zhang Yanyi1,Liao Wenjing1,Rao Yanxiao1,Gao Weijia1

Affiliation:

1. The Children’s Hospital, Zhejiang University

Abstract

Abstract Background: To comprehensively assess the effects of attention-deficit/hyperactivity disorder (ADHD) and its medication on the risks of depression and anxiety in children and adolescents. Methods: Comprehensive search was conducted in PubMed, Embase, Cochrane Library, and Web of Science until May 19, 2022. The outcomes were depression (depressive disorder, dysthymic disorder, major depressive disorder) and anxiety (anxiety disorder, generalized anxiety disorder, specific phobia, social phobia, separation anxiety disorder, panic disorder, agoraphobia, obsessive-compulsive disorder). Subgroup analysis was performed according to population (children <18 years old, adults ≥18 years old), sex (male, female) and duration of medication (<1 year, ≥1 year). Outcomes assessed by more than 10 studies were tested for publication bias through the Begg’s test. Results: Thirty-one studies were included in this systematic review and meta-analysis, with three only included for qualitative analysis. Individuals with ADHD had a significantly higher risk of depressive disorder than those without ADHD (pooled relative risk (RR)=2.26, 95% confidence interval (CI)=1.34-3.80, P=0.002). Subjects with ADHD were at a significantly higher risk of major depressive disorder than those without ADHD (pooled RR=2.24, 95%CI=1.31-3.82, P=0.003). Individuals with ADHD had a significantly increased risk of specific phobia versus those without ADHD (pooled RR=1.68, 95%CI=1.16-2.44, P=0.006). The risk of social phobia in the ADHD groupwas significantly higher than that in the non-ADHD group (pooled RR=1.71, 95%CI=1.13-2.61, P=0.012). Subjects with ADHD were at a significantly elevated risk compared with those without ADHD (pooled RR=4.99, 95%CI=1.51-16.56, P=0.009). No significant associations were observed between ADHD stimulant or non-stimulant medication and the risk of depression, and between ADHD stimulant medication and the risk of anxiety (all P>0.05). Conclusion: Children and adolescents with ADHD had higher risks of depressive disorder, major depressive disorder, specific phobia, social phobia, and agoraphobia than those without; ADHD medication had no significant effect on depression and anxiety.

Publisher

Research Square Platform LLC

Reference57 articles.

1. Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.Pediatrics. 2019;144.

2. Diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder;Colvin MK;J Clin Psychiatry,2015

3. ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity;Bélanger SA;Paediatr Child Health,2018

4. Young adult educational and vocational outcomes of children diagnosed with ADHD;Kuriyan AB;J Abnorm Child Psychol,2013

5. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review;Lee SS;Clin Psychol Rev,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3